OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600502 Anhui Construction Engineering Group Corporation
- 4.85
- +0.06+1.25%
Not Open Apr 1 15:00 CST
8.33BMarket Cap6.19P/E (TTM)
4.85High4.71Low412.92KlotVolume4.79Open4.79Pre Close197.51MTurnover2.41%Turnover Ratio6.19P/E (Static)1.72BShares5.3452wk High0.76P/B8.33BFloat Cap3.8252wk Low5.27Limit Up1.72BShs Float9.53Historical High4.31Limit Down2.92%Amplitude-1.07Historical Low0.26Dividend TTM4.78Avg Price191.30KlotAsk5.36%Div YieldTTM100Lot Size204.45KlotBid
Anhui Construction Engineering Group Corporation Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 5.76%96.5B | -9.96%53.96B | -10.70%33.46B | -16.25%13.54B | 13.88%91.24B | 11.16%59.93B | 11.23%37.47B | 11.25%16.17B | 12.31%80.12B | 8.44%53.91B |
| Operating revenue | 5.76%96.5B | -9.96%53.96B | -10.70%33.46B | -16.25%13.54B | 13.88%91.24B | 11.16%59.93B | 11.23%37.47B | 11.25%16.17B | 12.31%80.12B | 8.44%53.91B |
| Other operating revenue | 8.00%2.79B | ---- | -15.97%1.01B | ---- | 30.31%2.59B | ---- | 60.85%1.21B | ---- | 56.96%1.98B | ---- |
| Total operating cost | 5.85%91.64B | -9.48%52.16B | -10.56%32.23B | -15.95%13.15B | 12.85%86.58B | 10.13%57.63B | 9.97%36.04B | 10.65%15.64B | 12.30%76.72B | 8.86%52.33B |
| Operating cost | 5.81%84.54B | -10.58%47.37B | -11.91%29.2B | -18.26%11.78B | 12.89%79.9B | 9.73%52.98B | 9.84%33.15B | 11.24%14.41B | 11.69%70.77B | 8.06%48.28B |
| Operating tax surcharges | 9.38%303.25M | 8.22%228.63M | 24.92%174.95M | 11.37%83.07M | -11.64%277.24M | -0.50%211.27M | 5.09%140.05M | 35.09%74.59M | 5.07%313.76M | 0.79%212.34M |
| Operating expense | 13.17%273.16M | 7.61%202.36M | 11.33%135M | 28.36%72.58M | 20.39%241.37M | 42.18%188.05M | 38.10%121.26M | 34.49%56.55M | -19.89%200.49M | -25.44%132.26M |
| Administration expense | 5.84%2.37B | 7.33%1.58B | 10.00%1.03B | 12.43%559.56M | 12.30%2.24B | 9.86%1.47B | 5.37%938.61M | 0.84%497.71M | 12.65%1.99B | 15.94%1.34B |
| Financial expense | -3.59%2.02B | -2.29%1.5B | -8.52%970.43M | 20.37%484.18M | 6.18%2.09B | 9.54%1.53B | 17.82%1.06B | 0.72%402.26M | 36.83%1.97B | 23.30%1.4B |
| -Interest expense (Financial expense) | -2.15%2.42B | 2.74%1.63B | 0.06%1.08B | 6.20%534.18M | -3.50%2.47B | -2.52%1.58B | 0.84%1.08B | 5.82%503.02M | 19.42%2.56B | 15.18%1.62B |
| -Interest Income (Financial expense) | -27.21%-534.95M | -65.27%-397.59M | -111.33%-282.2M | -7.74%-148.31M | 35.11%-420.51M | 41.20%-240.57M | 53.54%-133.54M | 5.56%-137.65M | 11.07%-648M | -1.86%-409.14M |
| Research and development | 16.62%2.14B | 3.18%1.29B | 14.00%719.84M | -15.73%166.15M | 24.73%1.84B | 29.26%1.25B | 8.24%631.43M | 4.19%197.17M | 22.92%1.47B | 35.73%966.8M |
| Credit Impairment Loss | -3.93%-2.17B | -23.25%-307.27M | -171.25%-203.34M | 165.65%76.06M | -89.84%-2.09B | -305.82%-249.3M | -196.45%-74.97M | -65.13%28.63M | 11.47%-1.1B | 67.65%-61.43M |
| Asset Impairment Loss | -98.87%-191.26M | 110.56%6.02M | 110.47%6.14M | -92.45%3.71M | -1,227.30%-96.17M | -287.51%-56.95M | -1,008.51%-58.6M | 640.67%49.14M | 89.29%-7.25M | 34.02%-14.7M |
| Other net revenue | -9.53%-2.24B | 60.60%-157.8M | 36.88%-147.3M | 324.52%92.88M | -81.51%-2.04B | -763.10%-400.55M | -366.68%-233.37M | -75.00%21.88M | 7.37%-1.12B | 68.68%-46.41M |
| Fair value change income | --207.6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | -0.41%83.87M | 175.52%105.66M | 114.25%18.48M | 104.48%3.35M | 290.83%84.22M | -1,318.07%-139.91M | -4,292.85%-129.67M | -1,026.36%-74.72M | -198.28%-44.13M | -67.67%11.49M |
| -Including: Investment income associates | 68.75%22.21M | -72.06%2.48M | -70.90%7.2M | 0.80%-4.41M | 118.23%13.16M | 186.81%8.89M | 351.52%24.74M | -1,325.43%-4.45M | -347.72%-72.2M | -145.27%-10.24M |
| Asset deal income | 144.48%22.18M | 84.12%23.27M | 63.13%21.85M | -67.29%4.3M | 1,800.78%9.07M | 1,908.48%12.64M | 12,839.08%13.39M | 512,971.38%13.14M | -98.01%477.38K | -95.97%629.34K |
| Other revenue | -57.89%21.95M | -55.96%14.52M | -41.87%9.57M | -4.08%5.46M | 89.72%52.12M | 87.31%32.97M | 38.69%16.47M | -11.40%5.69M | -3.29%27.47M | 36.94%17.6M |
| Operating profit | 0.09%2.62B | -13.70%1.64B | -9.96%1.08B | -11.31%484.05M | 15.26%2.62B | 23.56%1.9B | 19.48%1.2B | 13.24%545.77M | 25.97%2.27B | 2.42%1.54B |
| Add:Non operating Income | 117.87%68.58M | 109.87%51.79M | 101.46%30.68M | 117.16%23.82M | -34.90%31.48M | -54.72%24.68M | -64.02%15.23M | -52.14%10.97M | 71.53%48.36M | 115.13%54.51M |
| Less:Non operating expense | 87.18%38.81M | 40.55%9.22M | 52.03%6.31M | 219.75%2.98M | 16.56%20.73M | -51.39%6.56M | -50.29%4.15M | -39.98%930.74K | -37.53%17.79M | -19.23%13.49M |
| Total profit | 0.81%2.65B | -12.29%1.68B | -8.77%1.11B | -9.16%504.9M | 14.19%2.63B | 21.50%1.92B | 16.64%1.21B | 10.43%555.82M | 27.69%2.3B | 4.55%1.58B |
| Less:Income tax cost | 8.69%621.98M | -19.67%379.8M | -21.06%247.17M | -9.08%107.86M | 21.62%572.26M | 42.98%472.82M | 48.97%313.11M | 14.89%118.62M | 20.51%470.55M | -7.51%330.68M |
| Net profit | -1.38%2.03B | -9.88%1.3B | -4.49%858.7M | -9.18%397.04M | 12.29%2.06B | 15.81%1.45B | 8.44%899.1M | 9.28%437.19M | 29.67%1.83B | 8.29%1.25B |
| Net profit from continuing operation | -1.38%2.03B | -9.88%1.3B | -4.49%858.7M | -9.18%397.04M | 12.29%2.06B | 15.81%1.45B | 8.44%899.1M | 9.28%437.19M | 29.67%1.83B | 8.29%1.25B |
| Less:Minority Profit | 35.75%684.48M | -10.80%341.59M | 0.97%245.75M | -3.09%86.83M | 11.43%504.21M | 19.74%382.96M | 16.78%243.39M | 1.90%89.59M | 42.54%452.48M | 12.04%319.84M |
| Net profit of parent company owners | -13.43%1.34B | -9.55%962.04M | -6.52%612.95M | -10.75%310.22M | 12.57%1.55B | 14.46%1.06B | 5.64%655.71M | 11.35%347.6M | 25.94%1.38B | 7.06%929.28M |
| Earning per share | ||||||||||
| Basic earning per share | -14.29%0.78 | -9.68%0.56 | -5.26%0.36 | -10.00%0.18 | 13.75%0.91 | 14.81%0.62 | 5.56%0.38 | 11.11%0.2 | 25.00%0.8 | 8.00%0.54 |
| Diluted earning per share | -14.29%0.78 | -9.68%0.56 | -5.26%0.36 | -10.00%0.18 | 13.75%0.91 | 14.81%0.62 | 5.56%0.38 | 11.11%0.2 | 25.00%0.8 | 8.00%0.54 |
| Other composite income | -5.06%-13.73M | 211.16%15.91M | 167.95%5.88M | 106.23%785.72K | -127.63%-13.07M | -131.36%-14.31M | -139.11%-8.66M | -185.31%-12.62M | 206.92%47.31M | 643.51%45.64M |
| Other composite income of parent company owners | -5.06%-13.73M | 211.16%15.91M | 167.95%5.88M | 106.23%785.72K | -127.63%-13.07M | -131.36%-14.31M | -139.11%-8.66M | -185.31%-12.62M | 206.92%47.31M | 643.51%45.64M |
| Total composite income | -1.42%2.02B | -7.87%1.32B | -2.90%864.59M | -6.30%397.83M | 8.77%2.04B | 10.62%1.43B | 4.60%890.44M | 2.34%424.57M | 37.31%1.88B | 13.07%1.29B |
| Total composite income of parent company owners | -13.58%1.33B | -6.80%977.95M | -4.36%618.83M | -7.16%311M | 7.92%1.54B | 7.63%1.05B | 0.66%647.05M | 2.46%334.98M | 35.73%1.43B | 13.41%974.92M |
| Total composite income of minority owners | 35.75%684.48M | -10.80%341.59M | 0.97%245.75M | -3.09%86.83M | 11.43%504.21M | 19.74%382.96M | 16.78%243.39M | 1.90%89.59M | 42.54%452.48M | 12.04%319.84M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.